Apr 29 |
Lexicon Pharmaceuticals announces retirement of CEO Lonnel Coats
|
Apr 29 |
Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals
|
Apr 29 |
Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024
|
Apr 22 |
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
|
Apr 18 |
Lexicon Pharmaceuticals to Host 2024 Investor Day
|
Apr 16 |
All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy
|
Apr 3 |
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 25 |
Lexicon Pharmaceuticals files to sell 57.66M shares for holders
|
Mar 25 |
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo
|
Mar 13 |
Lexicon (LXRX) Dips on Post Hoc Analysis Data on Sotagliflozin
|